Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Select Therapeutics submits pre-IND in Canada for anticancer compound

April 9, 1999

Aronex initiates phase I/II trial of Atragen in bladder cancer

April 9, 1999

EntreMed and NCI sign CRADA for 2-methoxyestradiol

April 8, 1999

Enzon files IND for PEG-camptothecin

April 8, 1999

Growth factor receptor PTK inhibitors in development by American Cyanamid

April 7, 1999

Schering-Plough seeks further E.U. approval for Temodal

April 7, 1999

FDA approves DepoCyt for treatment of lymphomatous meningitis

April 6, 1999

Celgene and NCI collaborate on thalidomide cancer trial

April 6, 1999

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Phase II trials of first anticancer dioxolane nucleoside analogue begin

April 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...